Dabrafenib Mesylate Capsules Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name	Dabrafenib Mesylate Capsules
Trade name	Tafinlar（泰菲乐）
Specification	50mg, 75mg
Main ingredients	Dabrafenib Mesylate
Dosage Form	Capsule
MA Holder	Novartis Europharm Limited
Category	Reference Listed Drugs (RLDs)

 

Indications:
BRAF is a protein kinase that plays a role in regulating genes that are responsible for cell replication and survival. This mutated form of BRAF appears to promote overgrowth of these cancer cells. Dabrafenib works by blocking the actions of the abnormal BRAF, inhibiting cell replication and potentially causing cell death.

 

For more details, pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

Hot Tags: dabrafenib mesylate capsules reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Argatroban Injection, Adefovir Dipivoxil Tablets, Phenytoin Sodium Tablets, Agomelatine Tablets, AdapaleneGel, Alfacalcidol Soft Capsules

• Previous: Trametinib Tablets Reference Listed Drug
• Next: Balanced Salt Solution Irrigating Reference Listed Drug